Once patients are stabilized annual or semiannual clinical evaluations and TSH monitoring are appropriate.[11] Long-term suppression of TSH values below normal values will frequently cause cardiac side-effects and contribute to decreases in bone mineral density (low TSH levels are also well known to contribute to osteoporosis)